Treatt Faces Revenue and Profit Dip Amid Takeover Bid

On Thursday, Treatt PLC (LON: TET), a manufacturer of natural extracts and ingredients, issued a trading update for the year ended September 30, 2025, revealing continued headwinds and a decline in key financial metrics.

This announcement arrives as the company navigates a recommended cash offer from Natara UK Bidco Limited, controlled by Exponent Private Equity LLP.

Revenue is anticipated to be approximately £130.6 million, a notable decrease from the £153.1 million reported in FY24.

Profit before tax and exceptional items (PBTE) is expected to be around £10.0 million, significantly lower than the £19.1 million achieved in the previous year.

The company attributes this downturn to lower demand in its Heritage segment due to persistently high citrus oil prices, coupled with softening consumer confidence, impacting demand in the North American market.

A breakdown of revenue performance across segments reveals a challenging year for the company. Heritage revenues experienced a 15% decrease, while Premium and New revenues declined by 13% and 17%, respectively.

Despite these declines, the revenue mix remained consistent with FY24, with Heritage contributing 68%, Premium 23%, and New 9% of total revenue.

Net debt increased to £5.9 million as of September 30, 2025, compared to £0.7 million in FY24. This increase reflects the impact of a £5 million share buyback program implemented during the year, even with the business maintaining robust cash generation and financial discipline.